Delivery Order SPE2DB25D7067-SPE2DB25FSVCJ
- Not listed
- The Defense Logistics Agency awarded a $3,414.82 delivery order to AmerisourceBergen Drug Corp for MOVIPREP Powder Packets under a firm fixed price contract. The award, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a non-competitive delivery order issued without set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,709.58 and a completion date of June 30, 2025. The award is for the supply of MOVIPREP POWDER PACKETS, a medical product. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of MOVIPREP powder packets, a bowel preparation medication, with a ceiling value of $1,233.66. This firm fixed-price contract, executed without a set-aside designation, represents a competitively awarded delivery order under the company's existing pharmaceutical supply agreement with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, with a potential value of $1,413.76, is for the provision of MOVIPREP POWDER PACKETS to be delivered by February 9, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- This federal contract award, valued at $3,214.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVIPREP POWDER PACKETS and has an ultimate completion date of April 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the Department of Defense. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a ceiling value of $1,554.48 and a performance period through July 8, 2025. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a ceiling value of $1,181.91 and a performance period through April 18, 2025. The contract is not set-aside and was awarded on a firm-fixed-price basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a ceiling value of $1,588.13 and a completion date of July 18, 2025. Amerisourcebergen Drug Corp, a for-profit organization, has been awarded this non-set-aside contract as part of its extensive portfolio of federal...
- This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical supply product, with a ceiling value of $1,801.88 and a performance period ending on May 14, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $15,620.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA to provide a range of...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVCJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MOVIPREP powder packets valued at $6,479.70 under a firm fixed price contract. The award was made on May 20, 2025, with an ultimate completion date of May 21, 2025, and represents a non-set-aside competitive award. MOVIPREP is a bowel preparation medication used prior to colonoscopy procedures, indicating this delivery supports medical supply needs for federal healthcare systems, likely serving military and veteran populations through the DLA supply chain. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The company's headquarters in Conshohocken, Pennsylvania aligns with the place of performance identified in this award, reflecting its role as a major pharmaceutical distributor serving federal medical procurement requirements through a competitive, indefinite delivery framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 5/20/25 |